US Only Archives - European Medical Journal

ACR 2025: CAR-T Therapies Show Promise in Autoimmune Disease

At ACR 2025, early data of CTA313, a universal CD19/BCMA CAR-T therapy, demonstrate safety and strong responses in refractory lupus, offering hope for durable remission.

ACR 2025: GLP-1 Drugs Reduce Rheumatoid Arthritis Flares

ACR 2025: GLP-1 Drugs Reduce Rheumatoid Arthritis Flares

New research presented at ACR 2025 shows GLP-1 receptor agonists, used for diabetes and obesity, may reduce rheumatoid arthritis flares and inflammation.

ACR 2025: Maternal Blood Markers Could Predict Fetal Heart Block

New research presented at ACR 2025 reveals IL-6 and CCL3 as predictive markers of fetal heart block in anti-Ro–positive pregnancies, paving the way for early detection and prevention.

Shifting the Silence in Pulmonary Fibrosis

Pulmonary fibrosis remains one of the most challenging respiratory diseases – often underdiagnosed, undertreated, and misunderstood…

Pulmonologists' Pocket Guide to Non-Small Cell Lung Cancer Care

From the first suspicion of lung cancer through diagnosis, treatment, and long-term management, pulmonologists remain central to the…

Paradigm Shift in ESR1 Testing: Spot Resistance Earlier

Explore ESR1 mutations in HR-positive breast cancer and how early ctDNA monitoring may help delay endocrine resistance…

Zongertinib: A New Option In HER2-Mutant NSCLC

HER2 (ERBB2)-mutant metastatic non-small cell lung cancer (NSCLC) remains a clinical challenge, with limited treatment options and…

11 Sep 2025

An FDA Approval for Certain Patients with Endometrial Cancer

Interview: Tina Tan

My mission and vision for IDSA during my tenure as President have been to continue advocating strongly for the society’s strategic…

The Role of IL-5 in Inflammatory Diseases

This infographic explores the expanding understanding of interleukin-5 (IL-5) in inflammatory diseases, highlighting that IL-5 impacts…